Clinical Trial Update: Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating cyclosporine in patients with ST-elevation myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: ST Elevation Acute Myocardial Infarction | Phase 3 | Status: COMPLETED